【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 The EC (European Commission) Classification
2.2.3 IVD Classification in Australia
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-Monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.2 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.3 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.3.1 Challenges in Regulations of MDx Tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment within the In Vitro Diagnostics Market, 2015-2025
3.1 Molecular Diagnostics in the IVD Market, 2014
3.2 Sales Forecast for the Global IVD Market 2015-2025
3.3 Molecular Diagnostics Gaining A Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2015-2025
4.1 The Molecular Diagnostic Market by Sectors, 2014
4.2 The Molecular Diagnostic Market by Sectors 2015-2025
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2015-2025
4.3 The Infectious Disease Testing Market 2015-2025
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2014
4.3.1.1 CT/NG
4.3.1.2 HPV Testing
4.3.1.3 HIV
4.3.1.4 Healthcare Associated Infections (HAI)
4.3.1.5 Hepatitis C (HCV)
4.3.1.6 Respiratory Infections
4.4 The Oncology Testing Market, 2015-2025
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Prostate Cancer Pipeline Biomarkers
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2015-2025
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2015-2025
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potential beyond Oncology
4.6.3 Cystic Fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory Diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA Typing) Market 2015-2025
4.7.1 Tissue Typing: Next-Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2015-2025
5.1 Regional Breakdown of the Global MDx Market, 2014
5.2 The Global MDx Market Forecast, 2015-2025
5.3 The Regional Market Shares of the MDx Market, 2014, 2019 and 2025
5.4 The US MDx Market 2014
5.4.1 The US MDx Market Forecast 2015-2025
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast 2015-2025
5.5.1 Changes in the Shares of the Leading European Markets, 2014, 2019 and 2025
5.5.2 Shares of the Major European Markets in a Global Context
5.5.3 The German MDx Market Forecast 2015-2025
5.5.3The French MDx Market Forecast 2015-2025
5.5.4 The Italian MDx Market Forecast 2015-2025
5.5.5 The Spanish MDx Market Forecast 2015-2025
5.5.6 The UK MDx Market Forecast 2015-2025
5.5.7 The Other European MDx Markets Forecast 2015-2025
5.6 The Japanese MDx Market Forecast 2015-2025
5.7 The Chinese MDx Market Forecast 2015-2025
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2015-2025
5.9 The Russian MDx Market Forecast 2015-2025
5.10 The Indian MDx Market Forecast 2015-2025
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2015-2025
5.12 The Mexican MDx Market Forecast 2015-2025
5.13 The Rest of the World Market Forecast 2015-2025
6. The Leading Companies in the Molecular Diagnostics Market, 2015
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2015-2025
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2014
6.1.3.1 Molecular Diagnostics Sales Performance, 2014
6.1.3.2 Molecular Diagnostic Sales by Region, 2014
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2015
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2015
6.1.5 Roche: Major M&A Activity and Strategic Partnerships Strengthen Position as Market Leader
6.1.5.1 Genia Acquisition to Strengthen DNA Sequencing Capabilities
6.1.5.2 IQuum Acquisition Allows Movement into POC MDx Market
6.1.5.3 Seragon Acquisition Strengthens Leading Position in Oncology
6.1.5.4 Santaris Acquisition Enchances Roche’s Position in RNA-Targeted Drugs Market
6.1.5.5 Bina Acquisition Brings Big Data Solution to Support NGS Development
6.1.5.6 Dutalys Acquisition Enhances Roche’s mAB Portfolio
6.1.5.7 Ariosa Acquisition Adds NIPT to MDx Portfolio
6.1.5.8 Foundation Medicine Deal Enhances Personalised Medicine Capabilities for Oncology
6.1.5.9 Signature and CAPP Acquisitions Strengthen Circulating DNA Testing Abilities
6.1.5.10 GENEWEAVE and Kapa Acquisitions Help Cement Roche’s Position as the MDx Market Leader
6.2 Qiagen NV
6.2.1 Sales and Recent Performance Analysis, 2014
6.2.2 Qiagen Sales by Region, 2014
6.2.3 Qiagen Sales by Segment, 2014
6.2.4 Qiagen: Molecular Diagnostics
6.2.5 Molecular Diagnostics: Product Expansion
6.2.5.1 QIASymphony
6.2.5.2 QuantiFERON-TB Gold: Expansion into Asia
6.2.5.3 Personalised Healthcare: Collaborative Efforts
6.2.5.4 Qiagen’s Software Company Acquisitions Cement Leadership in Bioinformatics
6.3 Hologic
6.3.1 Hologic Recent Sales Performance by Business Segment, 2014
6.3.2 Hologic Molecular Diagnostics: Product Portfolio
6.4 Becton, Dickinson and Company
6.4.1 Sales and Financial Performance, 2014
6.4.2 Sales and Financial Performance by Region, 2014
6.4.3 Becton, Dickinson and Company Diagnostics Sales and Financial Performance, 2013-2014
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 bioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2014
6.5.2 Sales by Region, 2014
6.5.3 Sales by Technology, 2014
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaborations with GSK and Novartis
6.5.6 Mergers, Acquisitions and Collaborations
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2014
6.6.2 Sales by Industry Segment, 2013-2014
6.6.3 Sales by Region, 2012-2014
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent Technologies
6.7.1 Sales and Recent Performance Analysis, 2014
6.7.2 Sales Performance by Business Segment, 2014
6.7.3 Agilent Technologies: Strong Player in Target Enrichment for Next-Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2015-2025
7.1 MDx Market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2015-2025
7.2.1 Strengths
7.2.1.1 Patient Demographics
7.2.1.2 Increased Awareness
7.2.1.3 High Growth in Oncology Molecular Diagnostics
7.2.1.4 Increasing Laboratory Test Menus
7.2.1.5 Personalised Medicine: Optimising Treatment Outcomes
7.2.2 Weaknesses
7.2.2.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.2.2.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.2.2.3 Consolidation of Healthcare Systems Increases Pricing Pressure
7.2.2.4 MDx: An Expensive, but Undervalued Diagnostic Tool
7.2.3 Opportunities
7.2.3.1 Next-Generation Sequencing
7.2.3.2 Emerging Markets
7.2.3.3 The Emergence of New Microorganisms
7.2.4 Threats
7.2.4.1 US Medical Device Excise Tax
7.2.4.2 Gene Patents: Controversial Ruling
7.3 Porter’s Five Forces Analysis of the MDx Market
7.3.1 Rivalry among Competitors [High]
7.3.2 Threat of New Entrants [Medium]
7.3.3 Power of Suppliers [Medium]
7.3.4 Power of Buyers [High]
7.3.5 Threat of Substitutes [High]
8. Research Interview
8.1 Kai te Kaat, Vice President, Global Product Management Life Sciences, Head of NGS Program, QIAGEN NV
8.1.1 QIAGEN: Pioneers in NGS Technology
8.1.2 The Future of NGS Outside Oncology
8.1.3 QIAGEN: Leading Progress in Bioinformatics
8.1.4 Regional Demand for NGS and NGS in the Wider Diagnostics Market
9. Conclusion
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
10. Glossary
【レポート販売概要】
■ タイトル：分子診断（MDx）の世界市場：感染症検査、腫瘍検査、血液検査、遺伝子検査、組織適合検査（HLA）■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies
■ 発行日：2015年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN5102608
■ 調査対象地域：グローバル
- SUP（スタンドアップパドルボード）の世界市場2019-2023About this market Adventure tourism is a niche growing segment of the tourism industry that focuses on traveling and exploring remote areas or places difficult to access and includes a lot of physical activity. Adventure tourism includes backpacking; climbing; rafting; paddle boarding; mountain biking, and snowboarding. The use of SUPs is growing in adventure tourism activities; and this is expect …
- 軍事用拡張現実（MAR）技術の世界市場2016-2026Visiongain assesses that the global Military Augmented Reality market will reach $1,311.3m in 2016 with significant prospects for growth. It is therefore critical that your strategic plans are timely and your forecasting plans are in place to take advantage of the business opportunities presented in this brand new study. Visiongain’s report will ensure that you keep informed and ahead of your comp …
- Abington Resources Ltd.：石油・ガスの開発・生産動向及びコスト分析- 2012Abington Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Abington Resources Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 産業用溶接ロボットの世界市場2015-2019About industrial welding robot Industrial robots are programmable automatically-operated machines (or robot systems) that have replaced human effort in industries. They are programmed to automate and control manufacturing processes. They are used in applications such as welding, painting, assembly, product inspection, testing, and packaging. Industrial robots that are used specifically for welding …
- リニアアクチュエーターの世界市場2018-202299 pages, November 2018 About this market The advent of Industry 4.0 and IoT have resulted in increasing demand for IoT enabled smart linear actuators. Functionalities such as rotary encoders, potentiometers, network switches, and controllers are being integrated into these smart actuators. Smart actuators are also being incorporated with various functions such as position feedback, switching, and …
- フルオロケイ酸の世界市場2019-2023Global Fluorosilicic Acid Market: About this market Technavio’s fluorosilicic acid market analysis considers sales from water fluoridation, chemical manufacturing, metal surface treatment, and electroplating, hide processing, and others. Our analysis also considers the sales of fluorosilicic acid in APAC, Europe, North America, South America, and MEA. In 2018, the water fluoridation segment had a …
- Mobile Local Search 2011: Location-based Search MarketMobile Local Search 2011 adds more intensive analysis and many new insights to the best selling research report published in 2010. The clear objective of this year’s research is to illuminate the economic landscape of mobile local search in China, Korea, and Japan along with powerful new entrants on the North American and EU leader boards. The deep coverage provides insight into the thought leader …
- ナトリウム低減成分の世界市場：アミノ酸、ミネラル塩、酵母エキスThe sodium reduction ingredients market by type is classified into amino acids, mineral salts, yeast extracts, and others that include hydrolyzed vegetable protein, trehalose, and nucleotides. The market for mineral salts was estimated to be the largest in 2014, and is projected to grow with the increasing demand from large-scale commercialization of nutritional food products. Reasons to Buy the R …
- 外骨格型装置（パワードスーツ）の世界市場：ヘルスケア用途、軍事用途、産業用途About Exoskeleton System An exoskeleton system is a man-machine system that combines human intelligence and machine power, thereby enabling individuals to gain super strength to walk or move. It is widely used across the Healthcare sector for rehabilitation. In rehabilitation centers, an exoskeleton system helps in tendon therapy and exercise. Individuals suffering from hip or knee conditions can …
- 世界におけるビジネス旅行者向けの空港小売市場動向（2014-2015）Summary “Global Business Travelers' Airport Retail Trends, 2014-2015” is a new report by Conlumino that globally analyzes prevailing trends in airport retailing and explores how business dynamics are set to change in 2014-2015. This highlights the key drivers and barriers influencing customer opinion and purchasing pattern, and identifies preferred product categories, frequently used payment modes …
- シャドー・バンキング・システムの世界市場2016-2020About the Shadow Banking Market A Shadow banking system is a network of financial institutions comprising non-depository banks like the structured investment vehicles, hedge funds, investment banks, and money market funds. Based on the size and scale of operations these financial intermediaries are classified as small to big insurance brokerage firms or financial institutions. The services offered …
- 産業用データ収集システムの世界市場2016-2020About the Industrial Data Acquisition Systems Market Data acquisition systems collect data from field devices like sensors or transmitters on parameters such as temperature, voltage, current, sound, and pressure through a wired or wireless network. With powerful microprocessors, standalone data acquisition systems (which can perform data acquisition more efficiently) have emerged in the market. Th …
- 世界のインテリジェントシステム市場動向（2012-2016）TechNavio's analysts forecast the Global Intelligent Systems market to grow at a CAGR of 16.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid development of ecosystems. The Global Intelligent Systems market has also been witnessing the increasing demand from emerging economies. However, the high ASPs of intelligent systems could pose a cha …
- 食品・サラダドレッシングの世界市場2016-2020About Food and Salad Dressings Food and salad dressings are used for garnishing and enhancing the taste of food products, especially salads, burgers, sandwiches, and other snack items. Some of the widely used dressings are mayonnaise, red wine oil, and vinegar and Caesar, Italian, and Russian dressings. Increased consumption of salads, as part of the move toward healthy eating, has created indirec …
- ポテトチップスの世界市場2016-2020About the Potato Chips Market The global potato chips market has been witnessing steady growth over the past few years. Initially, potato chips were available only in certain flavors. However, to attract new customers, the market vendors are offering potato chips in different flavors such as cinnamon, cheddar, and jalapeno. This is attracting many customers to try potato chips. Also, the availabil …
